AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and Equipment
AmanitaMushroom PoisoningAmanitinsFruiting Bodies, FungalSorption Detoxification

Tumor therapy with Amanita phalloides (death cap): stabilization of B-cell chronic lymphatic leukemia. (25/46)

 (+info)

pH-(low)-insertion-peptide (pHLIP) translocation of membrane impermeable phalloidin toxin inhibits cancer cell proliferation. (26/46)

 (+info)

Role of the clinical laboratory in guiding treatment of Amanita virosa mushroom poisoning: report of two cases. (27/46)

Historically, mortality after Amanita mushroom ingestion has ranged from 50% to 90%. Prompt diagnosis is imperative, and aggressive therapeutic measures must be instituted quickly to improve the outcome. We report successful treatment of two cases of A. virosa poisoning by use of combined therapies, including thioctic acid and hemoperfusion.  (+info)

Antamanide, a derivative of Amanita phalloides, is a novel inhibitor of the mitochondrial permeability transition pore. (28/46)

 (+info)

Peptide toxin components of Amanita exitialis basidiocarps. (29/46)

 (+info)

Amanita thiersii is a saprotrophic fungus expanding its range in the United States. (30/46)

 (+info)

Amanita poisonings resulting in acute, reversible renal failure: new cases, new toxic Amanita mushrooms. (31/46)

 (+info)

Geographically structured host specificity is caused by the range expansions and host shifts of a symbiotic fungus. (32/46)

 (+info)